Sugimoto, Toshitsugu

Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

Orimo, H., Nakamura, T., Hosoi, T., Iki, M., Uenishi, K., Endo, N., Ohta, H., Shiraki, M., Sugimoto, T., Suzuki, T., et al. (2012) · Archives of Osteoporosis

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 358

Advanced glycation end products, diabetes, and bone strength

Yamamoto, M., & Sugimoto, T. (2016) · Current Osteoporosis Reports

Advanced Glycation End Products researchBone health and osteoporosis research

Cited by 215

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases

Miyauchi, A., Matsumoto, T., Sugimoto, T., Tsujimoto, M., Warner, M. R., & Nakamura, T. (2010) · Bone

Bone health and osteoporosis researchBone health and treatments

Cited by 146

Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis

Okazaki, K., Yamaguchi, T., Tanaka, K.-I., Notsu, M., Ogawa, N., Yano, S., & Sugimoto, T. (2012) · Calcified Tissue International

Bone Metabolism and DiseasesAdvanced Glycation End Products research

Cited by 98

Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL–RANK interaction

Kanatani, M., Sugimoto, T., Sowa, H., Kobayashi, T., Kanzawa, M., & Chihara, K. (2004) · Journal of Cellular Physiology

Bone Metabolism and DiseasesThyroid Disorders and Treatments

Cited by 74

Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor.

Chen, Q., Kaji, H., Sugimoto, T., & Chihara, K. (2001) · FEBS Letters

Bone Metabolism and DiseasesEstrogen and related hormone effects

Cited by 63

Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study

Kaji, H., Kuroki, Y., Murakawa, Y., Funakawa, I., Funasaka, Y., Kanda, F., & Sugimoto, T. (2010) · Osteoporosis International

Bone health and osteoporosis researchBone health and treatments

Cited by 16

Papillary thyroid carcinoma is a risk factor for severe osteoporosis

Notsu, M., Yamauchi, M., Morita, M., Nawata, K., & Sugimoto, T. (2020) · Journal of Bone and Mineral Metabolism

Bone health and osteoporosis researchThyroid Cancer Diagnosis and Treatment

Cited by 10